BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kharkar PS. Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future Prospects. Curr Top Med Chem 2020;20:1564-75. [PMID: 32357816 DOI: 10.2174/1568026620666200502005853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kharkar PS. Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives. J Med Chem 2020;63:15279-307. [PMID: 33325699 DOI: 10.1021/acs.jmedchem.0c01336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Grassi ES, Ghiandai V, Persani L. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies. J Clin Med 2021;10:1455. [PMID: 33916320 DOI: 10.3390/jcm10071455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]